Andrey Anatolyevich Khmelevsky
Oncologist, Urologist.
Medicine of the future is not only about technology but also a return to humanity: each patient is not just a case in a medical history but a person, and treatment is based not only on protocols but also on compassion, where prevention is more important than treatment, and research and empathy are equal.
About Me
I don’t just treat diseases; I help people regain health by considering their lifestyle, psychology, and personal circumstances. For me, it’s not only the diagnosis that matters but also the person behind it. My practice is based on evidence-based medicine, an individual approach, and honest care. I help you understand your body and achieve long-term health.
Professional interests:
- Innovative Methods of Organ-Preserving Treatment
- Immunotherapy and Targeted Therapy in Urological Oncology
- Diagnosis and Treatment of Erectile Dysfunction
- Male infertility
- Therapy to Increase Your Own Testosterone
- Therapy for Chronic Prostatitis and Chronic Pelvic Pain Syndrome
- Optimization of Antibacterial Therapy for Urinary Tract Infections
About me
Education
| Start | Completion | Studies |
|---|---|---|
| 2005 | 2011 | Bashkir State Medical University |
| 2012 | 2012 | Residency. Oncology |
| 2012 | 2014 | Residency. Oncology |
| 2023 | 2023 | PP. Urology |
| text ss |
Advanced courses
| Year | Study |
|---|---|
| 2017 | Bashkir State Medical University. Palliative Care in Oncology 144h. |
| 2022 | Bashkir State Medical University. Palliative Care in Oncology 144 hours |
| 2020 | Federal State Budgetary Institution National Medical Research Center of Radiology, Ministry of Health of Russia. Basics of Carcinogenesis and Laboratory Technologies for Screening, Diagnosis, Therapy Selection, and Tissue Defect Reconstruction in Cancer Patients. 36 hours. |
| 2020 | Federal State Budgetary Institution National Medical Research Center for Radiology of the Ministry of Health of Russia. Current Issues in Drug Treatment of Malignant Neoplasms |
| 2020 | FSBI NMITs of Radiology, Ministry of Health of Russia. Fundamentals of Carcinogenesis and Laboratory Technologies for Screening, Diagnosis, Therapy Selection, and Tissue Defect Reconstruction in Cancer Patients. 36 hours |
| 2020 | FSBI NMRRC of the Ministry of Health of Russia. Current Issues in Drug Treatment of Malignant Neoplasms |
| 2022 | Periodic Accreditation in Specialty “”Oncology “” |
| 2024 | Primary Specialized Accreditation in the Specialty “”Urology “” |
Work Experience
2008 – 2010
Paramedic of the mobile team
EMS of Ufa
2012 – 2012
Oncologist
Clinic 46, Ufa
2012 – 2014
Oncologist
Polyclinic 52, Ufa
2014 – to the present time
Oncologist
GAUZ RKOD Ministry of Health RB
2025 – current time
Urologist Oncologist
V.S. Buzaev International Medical Centre
Research Publications
- LUNG CANCER / Gantsev Sh.Kh., Khmelevsky A.A. // Guide for Doctors, Moscow, 2020. –
- ASYMPTOMATIC KIDNEY TUMORS IN ELDERLY PATIENTS: REVIEW OF TREATMENT APPROACHES IN RUSSIA AND WESTERN COUNTRIES / Gantsev Sh.Kh., Gantsev K.Sh., Khmelevskiy A.A., Khrizman Y.N.//Advances in Gerontology.- 2020, T. 10 № 1. – S. 66-72
- ASYMPTOMATIC KIDNEY TUMORS IN ELDERLY PATIENTS: REVIEW OF TREATMENT APPROACHES IN RUSSIA AND WESTERN COUNTRIES / Gantsev Sh.Kh., Khmelevsky A.A., Gantsev K.Sh., Khrizman Yu.N. / / Advances in Gerontology. – 2019. – Vol. 32, No. 3. – P. 462-468
- USE OF BEVACIZUMAB + INTERFERON α-2A COMBINATION IN PATIENTS WITH DISSEMINATED KIDNEY CANCER COMPARED TO ACTIVE SURVEILLANCE GROUP / Creative Surgery and Oncology.- 2018, Vol. 8 ,№ 4. – S. 263-267.
- EFFECTIVENESS OF BEVACIZUMAB + INTERFERON α-2A IN PATIENTS WITH DISSEMINATED KIDNEY CANCER COMPARED TO THE ACTIVE SURVEILLANCE GROUP /Academic Journal of Western Siberia.- 2018, Vol. 14 № 5 (76). – S. 33-34
- EXPERIENCE OF LAPAROSCOPIC SURGERY IN THE TREATMENT OF RENAL CELL CARCINOMA AT THE REPUBLICAN CLINICAL ONCOLOGY DISPENSARY.- Khrizman Y.N., Gantsev K.Sh., Safiullin R.I., Khmelevsky A.A., Shakurov V.K., Aglamov R.I.- Creative Surgery and Oncology. 2017. Vol. 7 № 4
